| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $31.45M | - | |
| VP | 141.5K | $11.12M | - | |
| Other | 87.3K | $6.86M | - | |
| VP | 73.6K | $5.78M | -15,000 | |
| CFO | 70.1K | $5.50M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | Wierenga Wendell | Director | Sale+OE | 20,000 | $66.14 | $1,322,800.00 | -38.1% | -7.1% | - | |
| Dec 16, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,200 | $61.24 | $134,728.00 | -1.6% | -1.9% | - | |
| Dec 8, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 1,042 | $65.96 | $68,730.32 | -2.0% | -2.7% | - | |
| Dec 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 52,486 | $65.95 | $3,461,451.70 | -50.9% | -5.3% | - | |
| Dec 2, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,200 | $63.89 | $140,558.00 | -1.5% | -3.2% | - | |
| Dec 2, 2025 | Henderson John T65 | Director | Sale+OE | 8,750 | $63.90 | $559,125.00 | -10.5% | -3.2% | - | |
| Dec 1, 2025 | Kaye Edward M. Md46 | Director | Sale+OE | 28,064 | $66.72 | $1,872,430.08 | -73.8% | -6.9% | - | |
| Dec 1, 2025 | Harrington Robert Arthur51 | Director | Sell | 2,150 | $66.80 | $143,620.00 | -10.4% | -6.9% | - | |
| Nov 19, 2025 | Parshall B Lynne74 | Director | Sell | 5,000 | $64.73 | $323,650.00 | -17.9% | +2.8% | - | |
| Nov 18, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,200 | $66.45 | $146,190.00 | -1.5% | +0.7% | - |